Immune suppression via glucocorticoid-stimulated monocytes: A novel mechanism to cope with inflammation

Journal of Immunology

Volumn 193, Issue 3, 2014, Pages 1090-1099

  Varga, Georg ^a   Ehrchen, Jan ^a   Brockhausen, Anne ^a   Weinhage, Toni ^a   Nippe, Nadine ^a   Belz, Michael ^a   Tsianakas, Athanasios ^a   Ross, Matthias ^a   Bettenworth, Dominik ^a   Spieker, Tilmann ^a   Wolf, Marc ^a   Lippe, Ralph ^a   Tenbrock, Klaus ^b   Leenen, Pieter J M ^c   Roth, Johannes ^a   Sunderkötter, Cord ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; GAMMA INTERFERON; GLUCOCORTICOID; INTERLEUKIN 13; INTERLEUKIN 14; INTERLEUKIN 17;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELL STIMULATION; COLITIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MONOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; COCULTURE TECHNIQUES; COLITIS; DOWN-REGULATION; GLUCOCORTICOIDS; IMMUNE TOLERANCE; INFLAMMATION MEDIATORS; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES;

EID: 84906093223     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300891     Document Type: Article

References (53)

1. Almawi, W. Y., H. N. Beyhum, A. A. Rahme, and M. J. Rieder. 1996. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J. Leukoc. Biol. 60: 563-572.
2. Stahn, C., M. Löwenberg, D. W. Hommes, and F. Buttgereit. 2007. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol. Cell. Endocrinol. 275: 71-78.
3. Ma, W., K. Gee, W. Lim, K. Chambers, J. B. Angel, M. Kozlowski, and A. Kumar. 2004. Dexamethasone inhibits IL-12p40 production in lipopolysaccharidestimulated human monocytic cells by down-regulating the activity of c-Jun N-terminal kinase, the activation protein-1, and NF-kappa B transcription factors. J. Immunol. 172: 318-330.
4. Kleiman, A., and J. P. Tuckermann. 2007. Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice. Mol. Cell. Endocrinol. 275: 98-108.
5. Ogawa, S., J. Lozach, C. Benner, G. Pascual, R. K. Tangirala, S. Westin, A. Hoffmann, S. Subramaniam, M. David, M. G. Rosenfeld, and C. K. Glass. 2005. Molecular determinants of crosstalk between nuclear receptors and tolllike receptors. Cell 122: 707-721.
6. Patel, H. B., K. N. Kornerup, A. L. F. Sampaio, F. D'Acquisto, M. P. Seed, A. P. Girol, M. Gray, C. Pitzalis, S. M. Oliani, and M. Perretti. 2012. The impact of endogenous annexin A1 on glucocorticoid control of inflammatory arthritis. Ann. Rheum. Dis. 71: 1872-1880.
7. Perretti, M., and F. D'Acquisto. 2009. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat. Rev. Immunol. 9: 62-70.
8. Ehrchen, J., L. Steinmüller, K. Barczyk, K. Tenbrock, W. Nacken, M. Eisenacher, U. Nordhues, C. Sorg, C. Sunderkötter, and J. Roth. 2007. Glucocorticoids induce differentiation of a specifically activated, antiinflammatory subtype of human monocytes. Blood 109: 1265-1274.
9. Barczyk, K., J. Ehrchen, K. Tenbrock, M. Ahlmann, J. Kneidl, D. Viemann, and J. Roth. 2010. Glucocorticoids promote survival of anti-inflammatory macrophages via stimulation of adenosine receptor A3. Cancer 116: 1-3.
10. Tsianakas, A., G. Varga, K. Barczyk, G. Bode, N. Nippe, N. Kran, J. Roth, T. A. Luger, J. Ehrchen, and C. Sunderkoetter. 2012. Induction of an antiinflammatory human monocyte subtype is a unique property of glucocorticoids, but can be modified by IL-6 and IL-10. Immunobiology 217: 329-335.
11. Mosser, D. M. 2003. The many faces of macrophage activation. J. Leukoc. Biol. 73: 209-212.
12. Gordon, S., and P. R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5: 953-964.
13. Wells, C. A., T. Ravasi, and D. A. Hume. 2005. Inflammation suppressor genes: please switch out all the lights. J. Leukoc. Biol. 78: 9-13.
14. Auffray, C., M. H. Sieweke, and F. Geissmann. 2009. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27: 669-692.
15. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3: 23-35.
16. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8: 958-969.
17. Geissmann, F., S. Jung, and D. R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
18. Sunderkötter, C., T. Nikolic, M. J. Dillon, N. Van Rooijen, M. Stehling, D. A. Drevets, and P. J. M. Leenen. 2004. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 172: 4410-4417.
19. Strauss-Ayali, D., S. M. Conrad, and D. M. Mosser. 2007. Monocyte subpopulations and their differentiation patterns during infection. J. Leukoc. Biol. 82: 244-252.
20. Biermann, H., B. Pietz, R. Dreier, K. W. Schmid, C. Sorg, and C. Sunderkötter. 1999. Murine leukocytes with ring-shaped nuclei include granulocytes, monocytes, and their precursors. J. Leukoc. Biol. 65: 217-231.
21. Varga, G., J. Ehrchen, A. Tsianakas, K. Tenbrock, A. Rattenholl, S. Seeliger, M. Mack, J. Roth, and C. Sunderkoetter. 2008. Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloidderived suppressor cells. J. Leukoc. Biol. 84: 644-650.
22. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
23. Gabrilovich, D. I., S. Ostrand-Rosenberg, and V. Bronte. 2012. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12: 253-268.
24. Krummen, M. B. W., G. Varga, M. Steinert, A. Stuetz, T. A. Luger, and S. Grabbe. 2006. Effect of pimecrolimus vs. corticosteroids on murine bone marrow-derived dendritic cell differentiation, maturation and function. Exp. Dermatol. 15: 43-50.
25. Varga, G., S. Balkow, M. K. Wild, A. Stadtbaeumer, M. Krummen, T. Rothoeft, T. Higuchi, S. Beissert, K. Wethmar, K. Scharffetter-Kochanek, et al. 2007. Active MAC-1 (CD11b/CD18) on DCs inhibits full T-cell activation. Blood 109: 661-669.
26. Ahlmann, M., G. Varga, K. Sturm, R. Lippe, K. Benedyk, D. Viemann, T. Scholzen, J. Ehrchen, F. U. Müller, M. Seidl, et al. 2009. The cyclic AMP response element modulator alpha suppresses CD86 expression and APC function. J. Immunol. 182: 4167-4174.
27. Jonuleit, H., E. Schmitt, G. Schuler, J. Knop, and A. H. Enk. 2000. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192: 1213-1222.
28. Mombaerts, P., J. Iacomini, R. S. Johnson, K. Herrup, S. Tonegawa, and V. E. Papaioannou. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877.
29. Kannengiesser, K., C. Maaser, J. Heidemann, A. Luegering, M. Ross, T. Brzoska, M. Bohm, T. A. Luger, W. Domschke, and T. Kucharzik. 2008. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm. Bowel Dis. 14: 324-331.
30. Strober, W., I. J. Fuss, and R. S. Blumberg. 2002. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20: 495-549.
31. Lügering, A., T. Kucharzik, D. Soler, D. Picarella, J. T. Hudson, III, and I. R. Williams. 2003. Lymphoid precursors in intestinal cryptopatches express CCR6 and undergo dysregulated development in the absence of CCR6. J. Immunol. 171: 2208-2215.
32. Maloy, K. J. 2007. Induction and regulation of inflammatory bowel disease in immunodeficient mice by distinct CD4+ T-cell subsets. Methods Mol. Biol. 380: 327-335.
33. Zambon, A. C., S. Gaj, I. Ho, K. Hanspers, K. Vranizan, C. T. Evelo, B. R. Conklin, A. R. Pico, and N. Salomonis. 2012. GO-Elite: a flexible solution for pathway and ontology over-representation. Bioinformatics 28: 2209-2210.
34. Sica, A., and V. Bronte. 2007. Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 117: 1155-1166.
35. Tran, D. Q., J. Andersson, D. Hardwick, L. Bebris, G. G. Illei, and E. M. Shevach. 2009. Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures. Blood 113: 5125-5133.
36. Nocentini, G., S. Ronchetti, M. G. Petrillo, and C. Riccardi. 2012. Pharmacological modulation of GITRL/GITR system: therapeutic perspectives. Br. J. Pharmacol. 165: 2089-2099.
37. Schaer, D. A., J. T. Murphy, and J. D. Wolchok. 2012. Modulation of GITR for cancer immunotherapy. Curr. Opin. Immunol. 24: 217-224.
38. Brem-Exner, B. G., C. Sattler, J. A. Hutchinson, G. E. Koehl, K. Kronenberg, S. Farkas, S. Inoue, C. Blank, S. J. Knechtle, H. J. Schlitt, et al. 2008. Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. J. Immunol. 180: 335-349.
39. Solito, S., V. Bronte, and S. Mandruzzato. 2011. Antigen specificity of immune suppression by myeloid-derived suppressor cells. J. Leukoc. Biol. 90: 31-36.
40. Powrie, F., J. Carlino, M. W. Leach, S. Mauze, and R. L. Coffman. 1996. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J. Exp. Med. 183: 2669-2674.
41. Mudter, J., S. Wirtz, P. R. Galle, and M. F. Neurath. 2002-2003. A new model of chronic colitis in SCID mice induced by adoptive transfer of CD62L+ CD4+ T cells: insights into the regulatory role of interleukin-6 on apoptosis. Pathobiology 70: 170-176.
42. Elenkov, I. J. 2004. Glucocorticoids and the Th1/Th2 balance. Ann. N. Y. Acad. Sci. 1024: 138-146.
43. Nagaraj, S., M. Collazo, C. A. Corzo, J.-I. Youn, M. Ortiz, D. Quiceno, and D. I. Gabrilovich. 2009. Regulatory myeloid suppressor cells in health and disease. Cancer Res. 69: 7503-7506.
44. Gallina, G., L. Dolcetti, P. Serafini, C. De Santo, I. Marigo, M. P. Colombo, G. Basso, F. Brombacher, I. Borrello, P. Zanovello, et al. 2006. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J. Clin. Invest. 116: 2777-2790.
45. Huang, B., P.-Y. Pan, Q. Li, A. I. Sato, D. E. Levy, J. Bromberg, C. M. Divino, and S.-H. Chen. 2006. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 66: 1123-1131.
46. Blotta, M. H., R. H. DeKruyff, and D. T. Umetsu. 1997. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J. Immunol. 158: 5589-5595.
47. DeKruyff, R. H., Y. Fang, and D. T. Umetsu. 1998. Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting IL-12 production. J. Immunol. 160: 2231-2237.
48. Sinha, P., K. H. Parker, L. Horn, and S. Ostrand-Rosenberg. 2012. Tumorinduced myeloid-derived suppressor cell function is independent of IFN-g and IL-4Ra. Eur. J. Immunol. 42: 2052-2059.
49. Yang, R., Z. Cai, Y. Zhang, W. H. Yutzy, IV, K. F. Roby, and R. B. S. Roden. 2006. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells. Cancer Res. 66: 6807-6815.
50. Unger, W. W., S. Laban, F. S. Kleijwegt, A. R. van der Slik, and B. O. Roep. 2009. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur. J. Immunol. 39: 3147-3159.
51. Rea, D., C. van Kooten, K. E. van Meijgaarden, T. H. Ottenhoff, C. J. Melief, and R. Offringa. 2000. Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10. Blood 95: 3162-3167.
52. Liao, G., C. Detre, S. B. Berger, P. Engel, R. de Waal Malefyt, R. W. Herzog, A. K. Bhan, and C. Terhorst. 2012. Glucocorticoid-induced tumor necrosis factor receptor family-related protein regulates CD4(+)T cell-mediated colitis in mice. Gastroenterology 142: 582-591.e8.
53. Barnes, M. J., and T. Griseri, A. M. Johnson, W. Young, F. Powrie, and A. Izcue. 2012. CTLA-4 promotes Foxp3 induction and regulatory T cell accumulation in the intestinal lamina propria. Mucosal Immunol. 6: 324-334.